Tumoral MGMT content predicts survival in patients with aggressive pituitary tumors and pituitary carcinomas given treatment with temozolomide

D Bengtsson, HD Schrøder, K Berinder, D Maiter, C Hoybye, O Ragnarsson, U Feldt-Rasmussen, Å Krogh Rasmussen, AJ (Aart-Jan) van der Lely, M Petersson, G Johannsson, M Andersen, P Burman

Research output: Contribution to journalArticleAcademicpeer-review

17 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)737-739
Number of pages3
JournalEndocrine
Volume62
Issue number3
DOIs
Publication statusPublished - 2018

Cite this